Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-099083
Filing Date
2021-08-02
Accepted
2021-08-02 21:46:46
Documents
1
Period of Report
2021-08-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2123817-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2123817-2_4seq1.xml 4 3539
  Complete submission text file 0001104659-21-099083.txt   5289
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Reporting) CIK: 0001635088 (see all company filings)

State of Incorp.: D0 | Fiscal Year End: 0331
Type: 4 | Act: 34 | File No.: 001-38906 | Film No.: 211137695
SIC: 2834 Pharmaceutical Preparations

Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Issuer) CIK: 0001764013 (see all company filings)

EIN.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2836 Biological Products, (No Diagnostic Substances)